Stocksigma LogoStocksigma Logo

Senores Pharmaceuticals Reschedules Q2 FY27 Earnings Call to 29th Oct'26

Senores Pharmaceuticals Limited has rescheduled its earnings conference call to discuss Q2 and H1 FY27 financial results

Senores Pharmaceuticals Reschedules Q2 FY27 Earnings Call to 29th Oct'26

Senores Pharmaceuticals Ltd 路 Intimation 路 23 Oct 2026, 11:42 pm

Senores Pharmaceuticals Reschedules Q2 FY27 Earnings Call to 29th Oct'26 Senores Pharmaceuticals Limited has rescheduled its earnings conference call to discuss Q2 and H1 FY27 financial results. The call, hosted by DAM Capital Advisors Ltd, will now take place at 16:00 hrs IST on 29th Oct'26, advanced from the earlier scheduled time of 17:00 hrs IST. Senior management participants include Promoter & MD Swapnil Shah, Chairman Sanjay Majmudar, and Whole Time Director & CFO Deval Shah. The company confirmed that audio recordings and call transcripts will be made available on its website post-call.

Original exchange filing (PDF)

More announcements from Senores Pharmaceuticals Ltd

All Senores Pharmaceuticals Ltd announcements